Related Experiment Video
Updated: Aug 9, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Summary
Immunotherapy using Bacillus Calmette-Guerin (BCG) with cells improved survival in Acute Myeloid Leukemia (AML) patients by extending life post-relapse. BCG alone showed a potential benefit in one study, requiring further observation.
Area of Science:
- Oncology
- Immunology
- Hematology
Background:
- Acute Myeloid Leukemia (AML) is a complex hematologic malignancy.
- Immunotherapy is being explored as a treatment modality for AML.
- Bacillus Calmette-Guerin (BCG) is an immunotherapy agent with potential anti-cancer properties.
Purpose of the Study:
- To evaluate the efficacy of immunotherapy in AML treatment.
- To assess the impact of BCG and cell-based immunotherapy on patient survival.
- To determine the effectiveness of BCG monotherapy in AML.
Main Methods:
- Review of six studies on AML immunotherapy.
- Analysis of studies employing BCG in combination with cells.
- Analysis of studies utilizing BCG as a standalone therapy.
Main Results:
- Three studies using BCG and cells demonstrated prolonged survival in AML patients.
- The primary driver of extended survival was increased life expectancy after relapse.
- One of three studies using BCG alone indicated a beneficial effect on survival.
Conclusions:
- Combination immunotherapy with BCG and cells appears to prolong survival in AML.
- The extension of life after relapse is a critical factor in observed survival benefits.
- Further time is needed to confirm the efficacy of BCG monotherapy in AML treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.